Table 1.
Comparison of metabolic, inflammatory, and ASA resistance-related indicators between DM patients and the control group.
Fig 1.
Urinary 11dhTxB2 levels in DM patients and healthy controls at baseline and post-ASA administration.
Data are presented as median (IQR). *P = 0.001, **P = 0.007 vs. control group.
Fig 2.
Frequency distribution of urinary 11dhTxB2 Levels in DM patients and healthy controls at baseline and Post-ASA administration.
Table 2.
Univariate analysis results of aspirin resistance-related factors in DM.
Table 3.
Logistic regression analysis results of factors influencing ASA resistance in DM.
Table 4.
Logistic regression analysis of baseline 11dhTxB2 association with biochemical aspirin resistance in DM.
Table 5.
Results of multiple linear regression analysis of the difference in urinary 11dhTxB2 levels before and after ASA administration in DM patients.